Arakelyan Arsen, Nersisyan Lilit, Petrek Martin, Löffler-Wirth Henry, Binder Hans
Group of Bioinformatics, Institute of Molecular Biology, National Academy of SciencesYerevan, Armenia; College of Science and Engineering, American University of ArmeniaYerevan, Armenia.
Laboratory of Immunogenomics, Department of Pathological Physiology, Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University Olomouc Olomouc, Czech Republic.
Front Genet. 2016 May 6;7:79. doi: 10.3389/fgene.2016.00079. eCollection 2016.
Lung diseases are described by a wide variety of developmental mechanisms and clinical manifestations. Accurate classification and diagnosis of lung diseases are the bases for development of effective treatments. While extensive studies are conducted toward characterization of various lung diseases at molecular level, no systematic approach has been developed so far. Here we have applied a methodology for pathway-centered mining of high throughput gene expression data to describe a wide range of lung diseases in the light of shared and specific pathway activity profiles. We have applied an algorithm combining a Pathway Signal Flow (PSF) algorithm for estimation of pathway activity deregulation states in lung diseases and malignancies, and a Self Organizing Maps algorithm for classification and clustering of the pathway activity profiles. The analysis results allowed clearly distinguish between cancer and non-cancer lung diseases. Lung cancers were characterized by pathways implicated in cell proliferation, metabolism, while non-malignant lung diseases were characterized by deregulations in pathways involved in immune/inflammatory response and fibrotic tissue remodeling. In contrast to lung malignancies, chronic lung diseases had relatively heterogeneous pathway deregulation profiles. We identified three groups of interstitial lung diseases and showed that the development of characteristic pathological processes, such as fibrosis, can be initiated by deregulations in different signaling pathways. In conclusion, this paper describes the pathobiology of lung diseases from systems viewpoint using pathway centered high-dimensional data mining approach. Our results contribute largely to current understanding of pathological events in lung cancers and non-malignant lung diseases. Moreover, this paper provides new insight into molecular mechanisms of a number of interstitial lung diseases that have been studied to a lesser extent.
肺部疾病有着各种各样的发病机制和临床表现。准确分类和诊断肺部疾病是开发有效治疗方法的基础。尽管针对各种肺部疾病在分子水平上的特征进行了广泛研究,但迄今为止尚未开发出系统的方法。在此,我们应用了一种以通路为中心挖掘高通量基因表达数据的方法,根据共享和特定的通路活性谱来描述多种肺部疾病。我们应用了一种算法,该算法结合了用于估计肺部疾病和恶性肿瘤中通路活性失调状态的通路信号流(PSF)算法,以及用于对通路活性谱进行分类和聚类的自组织映射算法。分析结果能够清晰地区分癌症和非癌症肺部疾病。肺癌的特征在于与细胞增殖、代谢相关的通路,而非恶性肺部疾病的特征在于免疫/炎症反应和纤维化组织重塑相关通路的失调。与肺部恶性肿瘤不同,慢性肺部疾病的通路失调谱相对异质性。我们识别出三组间质性肺病,并表明特征性病理过程(如纤维化)的发展可由不同信号通路的失调引发。总之,本文使用以通路为中心的高维数据挖掘方法从系统角度描述了肺部疾病的病理生物学。我们的结果在很大程度上有助于当前对肺癌和非恶性肺部疾病中病理事件的理解。此外,本文为一些研究较少的间质性肺病的分子机制提供了新的见解。